CD4 and cancer: After adjusting for confounders, patients with CD4 count ≤500 cells/mm3 at baseline had higher hazards of OIs [AHR (95% CI) = 2.3 (2.0–2.6)] and malignancies [AHR (95% CI) = 1.2 (1.04–1.4)].